unknown
Stage
2018
Founded
1
Investors
About
Elixiron develops precision immunotherapies targeting neuroinflammation, autoimmune diseases, and cancer, with multiple drug candidates in clinical trials and an mRNA drug development platform.
Explore Elixiron's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.